FMR LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$263,891,065
-7.1%
6,768,173
+2.5%
0.02%
-10.5%
Q1 2024$284,208,782
+9.1%
6,601,830
+16.7%
0.02%
-5.0%
Q4 2023$260,511,767
+79.3%
5,655,922
+33.0%
0.02%
+53.8%
Q3 2023$145,277,903
-27.3%
4,252,866
-18.0%
0.01%
-23.5%
Q2 2023$199,765,220
-41.0%
5,188,707
-45.1%
0.02%
+13.3%
Q1 2023$338,419,432
+83.0%
9,455,698
+101.6%
0.02%
-16.7%
Q4 2022$184,959,387
+9.7%
4,690,829
+0.5%
0.02%0.0%
Q3 2022$168,578,000
+21.2%
4,669,759
+2.1%
0.02%
+28.6%
Q2 2022$139,091,000
+18.7%
4,572,368
+19.3%
0.01%
+55.6%
Q1 2022$117,190,000
-4.1%
3,833,476
-2.0%
0.01%0.0%
Q4 2021$122,149,000
+161.5%
3,910,017
+27.9%
0.01%
+125.0%
Q3 2021$46,707,000
-18.4%
3,056,756
-0.5%
0.00%0.0%
Q2 2021$57,209,000
+3.5%
3,072,444
-0.5%
0.00%
-20.0%
Q1 2021$55,262,000
+36.9%
3,087,244
+17.6%
0.01%
+25.0%
Q4 2020$40,381,000
+39.0%
2,625,552
+0.0%
0.00%
+33.3%
Q3 2020$29,055,000
+5.4%
2,624,620
+19.4%
0.00%0.0%
Q2 2020$27,576,000
+53.2%
2,199,054
+38.5%
0.00%
+50.0%
Q1 2020$18,003,000
+145.8%
1,587,536
+74.3%
0.00%
+100.0%
Q4 2015$7,324,000
-2.7%
910,9200.0%0.00%0.0%
Q3 2015$7,524,000
-42.8%
910,920
-20.2%
0.00%
-50.0%
Q2 2015$13,157,000
-37.9%
1,141,062
-9.2%
0.00%
-33.3%
Q1 2015$21,184,000
-14.6%
1,256,2390.0%0.00%0.0%
Q4 2014$24,811,0001,256,2390.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,754,266$107,388,8317.33%
Altium Capital Management LP 360,600$14,059,7945.74%
Affinity Asset Advisors, LLC 994,227$38,764,9114.47%
First Light Asset Management, LLC 1,306,260$50,931,0774.46%
Nan Fung Group Holdings Ltd 106,680$4,159,4534.44%
Ally Bridge Group (NY) LLC 169,369$6,603,6973.93%
TLS Advisors LLC 32,956$1,2853.22%
BRAIDWELL LP 2,560,573$99,836,7413.13%
Paradigm Biocapital Advisors LP 2,043,280$79,667,4873.05%
BRIDGER MANAGEMENT, LLC 146,800$5,723,7322.94%
View complete list of XENON PHARMACEUTICALS INC shareholders